(Q34220503)

31 July 2017

title

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates (English)

1 reference

31 July 2017

0 references

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

1 reference

primates

1 reference

2

Thomas W Geisbert

1 reference

31 July 2017

9

Gary J Nabel

1 reference

31 July 2017

8

Peter B Jahrling

1 reference

31 July 2017

5

Zhi-Yong Yang

1 reference

31 July 2017

6

Mario Roederer

1 reference

31 July 2017

7

Richard A Koup

1 reference

31 July 2017

1

Nancy J Sullivan

1 reference

31 July 2017

3

Joan B Geisbert

1 reference

31 July 2017

Ling Xu

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

424

1 reference

31 July 2017

issue

6949

1 reference

31 July 2017

page(s)

681-684

1 reference

Development of a preventive vaccine for Ebola virus infection in primates

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Immunization for Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Catastrophic ape decline in western equatorial Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE01876

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus

21 January 2018

1 reference

12 December 2020

Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro

1 reference

12 December 2020

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

1 reference

12 December 2020

Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE01876

1 reference

Dimensions Publication ID

31 July 2017

1044207686

0 references

1 reference